Search results
CARGO Therapeutics Adds Experienced Biopharma Executive to Board of Directors with the Appointment...
Benzinga· 10 hours ago– Appointment adds strategic finance and broad operating experience to Board as Company advances potentially pivotal Phase 2 clinical study for CAR T-cell
New 'armored' CAR produces responses in patients whose cancers don't respond to current CAR T cell...
Medical Xpress· 3 days agoA new "armored" form of CAR T cell therapy, developed by Carl June, MD, the Richard W. Vague Professor in Immunotherapy in the Perelman ...
Bristol Myers (BMY) Reports Positive Data on Breyanzi, Opdivo
Zacks via Yahoo Finance· 13 hours agoBristol Myers (BMY) announces positive data from three studies evaluating CAR T cell therapy...
Galapagos selects Adaptimmune T-cell therapy for $665M biobucks collab
FierceBiotech· 5 days agoAdaptimmune was facing a financing cliff until Galapagos walked in with a sprawling licensing deal...
...Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory...
Morningstar· 6 days agoU.S. Food and Drug Administration Approves Bristol Myers Squibb’s Breyanzi as a New CAR T Cell Therapy for Relapsed or Refractory Mantle ...
ASCO: New ‘Armored’ CAR produces significant r | Newswise
Newswise· 6 days agoCHICAGO – While CAR T cell therapy has revolutionized treatment for many blood cancers, including non-Hodgkin lymphoma (NHL), many patients ...
...Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate,...
Digital Journal· 5 days agoAdaptimmune and Galapagos to conduct clinical proof-of-concept trial to evaluate the safety and efficacy of uza-cel (next-generation MAGE-A4 TCR T-cell ...
Two-pronged attack strategy boosts immunotherapy in preclinical studies
Medical Xpress· 1 day agoThe research focuses on an immunotherapy called adoptive cell transfer (ACT), which involves extracting T cells from a patient, enhancing their ability to fight cancer, expanding them in culture ...
Improving cell therapy by creating T-cell 'super soldiers'
Medical Xpress· 6 days agoEach patient's unique tumor microenvironment, the complex and dynamic cells and molecules surrounding the tumor, can suppress immune cell activity and prevent the therapy ...
The role of CAR-T cells in systemic lupus erythematosus
Clinical Trials Arena via Yahoo Finance· 23 hours agoHowever, in November 2022, data from a 2022 study published in Nature Medicine by German researchers...